The ongoing COVID-19 pandemic necessitates an urgent need for rapid and yet methodologically rigorous clinical trials to identify the optimal combination of safe and effective treatments as well as rapid identification of candidate treatments that are harmful or ineffective. This need is particularly acute for treatments suitable for use in resource-limited settings, which require interventions that are widely available and inexpensive.
Source: JAMA Online First